Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. - Wikidata - awgldk - TriplyDB

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

http://www.wikidata.org/entity/Q43050091

about

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options Idiosyncratic adverse drug reactions: current concepts Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases Review article: the management of autoimmune hepatitis beyond consensus guidelines Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics Autoimmune-like drug-induced liver injury: a review and update for the clinician.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Chronic liver injury induced by drugs: a systematic review.Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.Anastrozole-related acute hepatitis with autoimmune features: a case report.Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy.Review article: autoimmune hepatitis -- current management and challenges.Xenobiotic exposure and autoimmune hepatitis Autoimmune hepatitis: current challenges and future prospects.Tracing environmental markers of autoimmunity: introducing the infectome.The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.Liraglutide-induced autoimmune hepatitis Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report.Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate.Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines Liver injury from nonsteroidal anti-inflammatory drugs in the United States.Epidemiology and treatment of autoimmune hepatitis.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists.An Update on Drug-induced Liver Injury.Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.Black Cohosh Hepatotoxicity with Autoimmune Hepatitis Presentation.Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.Review article: drug-induced liver injury in clinical practice.Idiosyncratic drug-induced liver injury: a clinical update.Drug-induced autoimmune-like hepatitis.Drug-induced liver injury: a summary of recent advances.

P2860

Q26749054-9293A7C8-EBDB-440D-8D9A-0F159724F62E Q26781892-37F386A5-5778-404A-91B0-5C81FB1CC2BB Q26824391-7AC0D979-ECCA-487D-9842-4D4E951AF305 Q26827599-8108FEE5-C1CE-4E72-A3DD-1B51EFAFD42D Q26864098-351BE78C-3DB6-4996-AC27-A823B6FBEFFB Q26864272-482FB2A1-DAC3-4D38-A295-42C25077DBE8 Q28087726-FAA5FAA0-024F-4BF8-8B36-1B056E9A9E58 Q30276377-B0909F0C-23AF-44BD-A535-B5BF53B49562 Q30277969-DAF63E3F-9FB7-4C57-B0FE-7FA9CD0D16B8 Q30278737-680D3AE3-43AF-434B-829C-E522C8B17C15 Q33403301-C0FC1E8E-4BB5-40B8-AB3F-2F62352E2756 Q33431503-04379346-CF01-44BE-8F74-39247E5401DB Q33563872-F8ADD54B-DBBF-4B9E-BB92-323083D004F7 Q33859044-D265FA9A-F427-49DE-B8B5-79D366C4B7D7 Q33873000-AB75BE61-ECD2-4D28-91EC-B79BCA80893F Q34369116-B841D61B-53EA-4818-B637-3DBFB15A6187 Q34495354-B0012FBC-FFD5-4C20-B4B8-CC3FE6BEF7D7 Q34550808-34A79AB6-D323-4DD8-8FF0-41BCD4CD15E3 Q34671373-8BD8824F-5F96-46DE-BE0D-9C768A96E2C0 Q35341829-3D48073C-059E-42E3-9B9E-446D538EE80F Q35580550-C938DE05-09FB-4BF8-A5E6-A66F021AC1B0 Q35885041-64D30721-CC15-4342-8FCC-291793BC62C5 Q36085618-8F33500B-A0C1-452D-A848-759E4EB9F80E Q36405278-416F25C4-51AC-4027-9B5A-75380FCD114C Q36490242-3300844B-1615-48D7-9604-905B30A8FF13 Q36503222-CDECF0DE-EBDA-4226-AF22-A3C1C1ECD238 Q36954477-F1EA3218-A159-4982-8C82-84D515147619 Q37229883-9E4BBDE3-EB7A-4AA8-9BF4-74DAD1248EE8 Q37280079-EF49AD55-1496-48A3-A736-BDE765D3F46D Q37356353-A3B0EED4-0AB3-4CAB-8570-EF1284E6F006 Q37590883-80750115-2EF6-4F20-AF22-BBD7B061804C Q37612024-7BCDDF1A-832B-47D0-90BA-47203FE55276 Q37613520-B347DAB1-C011-4923-AB3F-05245549C063 Q37627507-96647AB7-8043-49F6-A349-17DFB17BBC79 Q37634909-21447985-D3F2-4829-A811-D806602D2254 Q37694102-26B592C5-49DB-4103-8C37-36E77F26A178 Q37726069-79191FD6-BC11-4CE2-8668-1E10EC075BA1 Q37806980-4BFD21CA-AB55-483C-B773-7683CED9FED9 Q37843783-1DF4DD4E-2CE8-4DB4-BC98-214ADB8ED58A Q37867695-7331FE5E-4E8A-46DC-872E-2170BCCA0710

P2860

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

http://www.wikidata.org/entity/Q43050091

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@en

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@nl

type

label

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@en

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@nl

prefLabel

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@en

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

@nl

P1433

Q43050091-3399A36B-2E67-4B55-8850-8EABCCFE3486

P1476

Q43050091-D71271A0-92F9-47B9-B62D-5FDC94B754C2

P2093

Q43050091-1871CB09-BD61-40B0-8616-13F3D799EAD6

Q43050091-8D225F11-9A08-4324-A48D-4AFEEB5F6270

Q43050091-AC0A7600-58D9-4227-8288-1FBE56D9CFE9

Q43050091-AD0F3ED2-3C4B-49C0-888A-F3494D33E6FB

Q43050091-B7D86A6F-F22F-449F-A824-4FE61716C0C6

Q43050091-BB46B5FE-342B-4C4E-9CD0-C1861133933A

Q43050091-D9EB6471-C76E-4F80-A589-4D7A63F0FFF8

P2860

Q43050091-1D66FAE7-931E-43C3-81A5-87F6C0A73B2D

Q43050091-1EEAA103-2A3D-48FD-8250-E47B34D091EC

Q43050091-28FC9CE8-69E1-4BFF-BB2A-04714A6813E9

Q43050091-43539FB3-01C4-4FD9-94E4-0CC08E68801C

Q43050091-4D54A4C0-7081-468E-A9CA-6337F1A65132

Q43050091-526ABDFA-28A3-4840-8A7F-D44CDE0D5CFF

Q43050091-5427E006-5FDF-4042-8FDF-BF7D801D6A12

Q43050091-54ADB1EB-98FC-4C14-A57B-4B8FB251187A

Q43050091-54B0F025-6AC3-4F0F-A32D-4CD03ADBBEC6

Q43050091-712D25E5-A8C9-4726-8DEF-1FD1CC08F3E4

P304

Q43050091-3FED416C-877A-4EE8-B634-7B930CE8D828

P31

Q43050091-58426C4B-A645-4791-A80D-18EFCEF0BEDB

P356

Q43050091-8F3E97C8-4717-4F51-ABB2-7A3A901AF467

P407

Q43050091-5188FA3C-5B77-41DA-85A8-2F25DEEFC2F7

P433

Q43050091-9812B1F0-4071-460C-982F-52C7CB47B527

P478

Q43050091-C2EB3B41-5E27-4BBD-8C5F-0D2E8188881C

P50

Q43050091-ACE528E9-A2C2-4F3B-880C-EB21170870E4

P577

Q43050091-AD129929-8D76-45D2-8211-479895D781ED

P5875

Q43050091-A4F37A95-BB93-40CA-98D6-0A02C66AA009

P698

Q43050091-4EA3E279-2DA4-44DC-ADB6-F949660AC108

P356

P1433

P1476

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis

@en

P2093

Einar Björnsson

http://www.w3.org/2001/XMLSchema#string

Jayant Talwalkar

http://www.w3.org/2001/XMLSchema#string

Keith Lindor

http://www.w3.org/2001/XMLSchema#string

Matthias Neuhauser

http://www.w3.org/2001/XMLSchema#string

Naoki Takahashi

http://www.w3.org/2001/XMLSchema#string

Patrick S Kamath

http://www.w3.org/2001/XMLSchema#string

Schuyler Sanderson

http://www.w3.org/2001/XMLSchema#string

P2860

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

Letter: Chronic active hepatitis induced by nitrofurantoin

Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases.

Immune-mediated drug-induced liver disease.

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis.

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis.

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.

P304

2040-2048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23588

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Sombat Treeprasertsuk

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44640163

http://www.w3.org/2001/XMLSchema#string

P698

20512992

http://www.w3.org/2001/XMLSchema#string